Home > Homepage – Non USA

Building a healthier
Tomorrow

for people with progressive non-viral liver diseases.

Learn more about OUR FOCUS >

Latest News

Sep 30, 2022
Intercept Pharmaceuticals Announces REVERSE Phase 3 Study of Obeticholic Acid (OCA) in Compensated Cirrhosis due to NASH Did Not Meet its Primary Endpoint
VIEW ALL PRESS RELEASES >

Exploring Racial Differences and Disparities in PBC Care

Hear provider and patient perspectives from a multidisciplinary roundtable discussion
conducted in the U.S.
VIEW THE ROUNDTABLE >

OUR STORY

Our story dates back nearly 40 years. Since 2002, we’ve pioneered a novel scientific platform to answer critical needs in the liver health community.

Medical Information

If you are a healthcare professional and have a medical inquiry, visit our Medical Information website.

Join Our Team

We are looking for enthusiastic and hard-working individuals who embody our values as we grow the Intercept team.

03/2021 GL-NP-N/A-0094